Simon L. Croft

21.7k total citations · 6 hit papers
210 papers, 16.2k citations indexed

About

Simon L. Croft is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Organic Chemistry. According to data from OpenAlex, Simon L. Croft has authored 210 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Public Health, Environmental and Occupational Health, 105 papers in Epidemiology and 61 papers in Organic Chemistry. Recurrent topics in Simon L. Croft's work include Research on Leishmaniasis Studies (139 papers), Trypanosoma species research and implications (102 papers) and Synthesis and Biological Evaluation (43 papers). Simon L. Croft is often cited by papers focused on Research on Leishmaniasis Studies (139 papers), Trypanosoma species research and implications (102 papers) and Synthesis and Biological Evaluation (43 papers). Simon L. Croft collaborates with scholars based in United Kingdom, United States and Switzerland. Simon L. Croft's co-authors include Alan H. Fairlamb, Shyam Sundar, Marleen Boelaert, Vanessa Yardley, Sakib Burza, Graham H. Coombs, Karin Seifert, Piero Olliaro, R.A. Neal and Reto Brun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Angewandte Chemie International Edition.

In The Last Decade

Simon L. Croft

209 papers receiving 15.6k citations

Hit Papers

Drug Resistance in Leishmaniasis 2002 2026 2010 2018 2006 2018 2003 2004 2002 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Drug Resistance in Leishmaniasis
    2006 1.3k citations Simon L. Croft, Shyam Sundar et al. profile →
  2. Leishmaniasis
    2018 1.3k citations Simon L. Croft et al. The Lancet profile →
  3. Leishmaniasis– current chemotherapy and recent advances in the search for novel drugs
    2003 706 citations Simon L. Croft et al. Trends in Parasitology profile →
  4. Antimalarial drug discovery: efficacy models for compound screening
    2004 663 citations Simon L. Croft et al. profile →
  5. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda
    2002 592 citations Shyam Sundar, Simon L. Croft et al. profile →
  6. Kinetoplastids: related protozoan pathogens, different diseases
    2008 431 citations Simon L. Croft et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon L. Croft United Kingdom 63 10.9k 6.6k 4.6k 3.5k 1.8k 210 16.2k
Reto Brun Switzerland 70 7.9k 0.7× 6.7k 1.0× 8.0k 1.7× 6.6k 1.9× 2.1k 1.2× 489 20.6k
Alan H. Fairlamb United Kingdom 67 9.4k 0.9× 9.1k 1.4× 4.4k 1.0× 6.2k 1.8× 946 0.5× 264 16.0k
Shyam Sundar India 76 19.8k 1.8× 12.0k 1.8× 3.0k 0.6× 2.2k 0.6× 1.3k 0.7× 431 23.1k
Philip J. Rosenthal United States 83 14.1k 1.3× 2.9k 0.4× 4.7k 1.0× 4.8k 1.4× 1.0k 0.6× 480 23.2k
Louis Maes Belgium 53 3.6k 0.3× 2.6k 0.4× 2.7k 0.6× 3.7k 1.0× 2.1k 1.2× 360 11.3k
Marc Ouellette Canada 70 8.4k 0.8× 7.1k 1.1× 1.2k 0.3× 4.6k 1.3× 944 0.5× 235 14.5k
Marcel Kaiser Switzerland 54 3.4k 0.3× 2.8k 0.4× 4.9k 1.0× 4.9k 1.4× 1.7k 1.0× 513 13.0k
Julio A. Urbina Venezuela 61 5.5k 0.5× 6.5k 1.0× 3.3k 0.7× 3.2k 0.9× 472 0.3× 149 9.8k
David A. Fidock United States 71 13.6k 1.2× 2.0k 0.3× 1.3k 0.3× 3.7k 1.1× 529 0.3× 217 17.2k
Vanessa Yardley United Kingdom 48 3.9k 0.4× 2.6k 0.4× 2.9k 0.6× 1.7k 0.5× 608 0.3× 139 7.0k

Countries citing papers authored by Simon L. Croft

Since Specialization
Citations

This map shows the geographic impact of Simon L. Croft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon L. Croft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon L. Croft more than expected).

Fields of papers citing papers by Simon L. Croft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon L. Croft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon L. Croft. The network helps show where Simon L. Croft may publish in the future.

Co-authorship network of co-authors of Simon L. Croft

This figure shows the co-authorship network connecting the top 25 collaborators of Simon L. Croft. A scholar is included among the top collaborators of Simon L. Croft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon L. Croft. Simon L. Croft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chatterjee, Kingshuk, et al.. (2023). Dermal microdialysis: A method to determine drug levels in the skin of patients with Post kala-azar dermal leishmaniasis (PKDL). Experimental Parasitology. 257. 108687–108687.
2.
Sanderson, Lisa, Marcelo Alves da Silva, Rachel C. Brown, et al.. (2021). Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug. PLoS neglected tropical diseases. 15(4). e0009276–e0009276. 4 indexed citations
3.
Bocxlaer, Katrien Van, Vanessa Yardley, Mohammad S. Alavijeh, et al.. (2018). Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis. International Journal for Parasitology Drugs and Drug Resistance. 8(2). 223–228. 37 indexed citations
4.
Barrett, Michael P. & Simon L. Croft. (2014). Emerging paradigms in anti-infective drug design. Parasitology. 141(1). 1–7. 7 indexed citations
5.
McLatchie, Alex P., Hollie Burrell‐Saward, Elmarie Myburgh, et al.. (2013). Highly Sensitive In Vivo Imaging of Trypanosoma brucei Expressing “Red-Shifted” Luciferase. PLoS neglected tropical diseases. 7(11). e2571–e2571. 51 indexed citations
6.
Staines, Henry M., Simon L. Croft, & Paul Horrocks. (2011). Developing novel strategies to prevent parasitic infections. Expert Review of Anti-infective Therapy. 9(7). 783–785. 1 indexed citations
7.
Dujardin, Jean‐Claude, Dolores González‐Pacanowska, Simon L. Croft, Ole F. Olesen, & Gérald F. Späth. (2010). Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas. Trends in Parasitology. 26(8). 395–403. 36 indexed citations
8.
Croft, Simon L. & Juergen Engel. (2006). Miltefosine – discovery of the antileishmanial activity of phospholipid derivatives. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100. S4–S8. 128 indexed citations
9.
Pérez‐Victoria, F. Javier, María P. Sánchez‐Cañete, Karin Seifert, et al.. (2006). Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use. Drug Resistance Updates. 9(1-2). 26–39. 147 indexed citations
10.
Ohkanda, Junko, Howard Kendrick, Kohei Yokoyama, et al.. (2004). In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability. Bioorganic & Medicinal Chemistry. 12(24). 6517–6526. 35 indexed citations
11.
Seifert, Karin, et al.. (2003). Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). International Journal of Antimicrobial Agents. 22(4). 380–387. 137 indexed citations
12.
Camacho‐Corona, María del Rayo, J. David Phillipson, Simon L. Croft, et al.. (2001). Terpenoids from Guarea rhophalocarpa. Phytochemistry. 56(2). 203–210. 32 indexed citations
13.
Addae-Kyereme, Jonathan, Simon L. Croft, Howard Kendrick, & Colin W. Wright. (2001). Antiplasmodial activities of some Ghanaian plants traditionally used for fever/malaria treatment and of some alkaloids isolated from Pleiocarpa mutica; in vivo antimalarial activity of pleiocarpine. Journal of Ethnopharmacology. 76(1). 99–103. 59 indexed citations
14.
Camacho‐Corona, María del Rayo, Rachel Mata, Geoffrey C. Kirby, et al.. (2000). Bioactive Compounds from Celaenodendron mexicanum. Planta Medica. 66(5). 463–468. 53 indexed citations
15.
Leite, Virgínia Hora Rios & Simon L. Croft. (1996). Hepatic extracellular matrix in BALB/c mice infected with Leishmania donovani. International Journal of Experimental Pathology. 77(4). 181–190. 7 indexed citations
16.
Maarouf, Mohammad, et al.. (1995). Ribosomes ofLeishmania are a target for the aminoglycosides. Parasitology Research. 81(5). 421–425. 47 indexed citations
17.
Croft, Simon L.. (1994). A rationale for antiparasite drug discovery. Parasitology Today. 10(10). 385–386. 7 indexed citations
18.
Croft, Simon L., et al.. (1992). An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1. Acta Tropica. 51(3-4). 237–245. 62 indexed citations
19.
Davidson, R.N., Andrew M. Scott, Mala K. Maini, A.D.M. Bryceson, & Simon L. Croft. (1991). Liposomal amphotericin B in drug-resistant visceral leishmaniasis. The Lancet. 337(8749). 1061–1062. 142 indexed citations
20.
Long, Stephen P., et al.. (1989). Analysis of spatial variation in CO2 uptake within the intact leaf and its significance in interpreting the effects of environmental stress on photosynthesis. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 323(1216). 385–395. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reto Brun Breakdown of academic impact, for papers by Alan H. Fairlamb Breakdown of academic impact, for papers by Shyam Sundar Breakdown of academic impact, for papers by Philip J. Rosenthal Breakdown of academic impact, for papers by Louis Maes Breakdown of academic impact, for papers by Marc Ouellette Breakdown of academic impact, for papers by Marcel Kaiser Breakdown of academic impact, for papers by Julio A. Urbina Breakdown of academic impact, for papers by David A. Fidock Breakdown of academic impact, for papers by Vanessa Yardley
Rankless by CCL
2026